ID   YSK-21
AC   CVCL_E942
DR   IARC_TP53; 16155
DR   Wikidata; Q54995525
RX   PubMed=11550287;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=11550287).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12003; TP73; Zygosity=Heterozygous (PubMed=11550287).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn288Tyr (c.862A>T); Zygosity=Hemizygous (PubMed=11550287).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48-49Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=11550287; DOI=10.1002/gcc.1181;
RA   Inokuchi K., Hamaguchi H., Taniwaki M., Yamaguchi H., Tanosaki S.,
RA   Dan K.;
RT   "Establishment of a cell line with AML1-MTG8, TP53, and TP73
RT   abnormalities from acute myelogenous leukemia.";
RL   Genes Chromosomes Cancer 32:182-187(2001).
//